Literature DB >> 8779976

Glycine minimizes reperfusion injury in a low-flow, reflow liver perfusion model in the rat.

Z Zhong1, S Jones, R G Thurman.   

Abstract

This study investigated the effects of glycine on reperfusion injury in a low-flow, reflow liver perfusion model. With this protocol, livers were perfused at low flow rates of approximately 1 ml.g-1. min-1 for 75 min, which caused cells in pericentral regions of the liver lobule to become anoxic because of insufficient delivery of oxygen. When normal flow rates (approximately 4 ml.g-1.min-1) were restored for 40 min, an oxygen-dependent reperfusion injury occurred. Upon reflow, lactate dehydrogenase (LDH), a cytosolic enzyme, and malondialdehyde (MDA), an end product of lipid peroxidation, were released into the effluent perfusate. LDH increased from basal levels of approximately 1-35 IU.g-1.h-1 in livers from control rats. Glycine (0.06-2.00 mM) minimized enzyme release in a dose-dependent manner (half-maximal decrease = 133 microM), with maximal values only reaching 5 IU.g-1.h-1 when glycine was increased to 2 mM. Reflow for 40 min after 75 min of low-flow hypoxia caused death in approximately 30% of previously anoxic parenchymal cells in pericentral regions; however, infusion of glycine (2 mM) decreased cell death to less than 10%. Strychnine (1 mM), which was found to mimic the cytoprotective effect of glycine in proximal renal tubules, also reduced LDH release to 11 IU.g-1.h-1 in this study. Bile was released at rates of approximately 42 microliters.g-1.h-1 in livers from control rats, but values were not altered significantly by glycine. Maximal MDA production during reperfusion decreased by 35% with 0.6 mM of glycine. Trypan blue distribution time, an indicator of hepatic microcirculation, was reduced significantly by glycine at 5 and 40 min after reflow, but changes were about twofold greater at later time points compared with earlier ones (half-maximal decrease = 225 microM). Time for oxygen to reach steady state upon reflow was reduced by glycine in a dose-dependent manner, and the rates of entry and exit of a dye confined to vascular space (fluorescein dextran) were increased two- to threefold by glycine, respectively. Taken together, these data indicate that a reperfusion injury that occurs in previously hypoxic pericentral regions of the liver upon reintroduction of oxygen is minimized by glycine, possibly by action on a glycine-sensitive anion channel to improve microcirculation during the reperfusion period.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8779976     DOI: 10.1152/ajpgi.1996.270.2.G332

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

1.  Intracellular Ca2+ thresholds that determine survival or death of energy-deprived cells.

Authors:  Z Dong; P Saikumar; G A Griess; J M Weinberg; M A Venkatachalam
Journal:  Am J Pathol       Date:  1998-01       Impact factor: 4.307

2.  Protection of ATP-depleted cells by impermeant strychnine derivatives: implications for glycine cytoprotection.

Authors:  Z Dong; M A Venkatachalam; J M Weinberg; P Saikumar; Y Patel
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

Review 3.  The role of glycine in regulated cell death.

Authors:  Joel M Weinberg; Anja Bienholz; M A Venkatachalam
Journal:  Cell Mol Life Sci       Date:  2016-04-11       Impact factor: 9.261

Review 4.  Glycine, a simple physiological compound protecting by yet puzzling mechanism(s) against ischaemia-reperfusion injury: current knowledge.

Authors:  Frank Petrat; Kerstin Boengler; Rainer Schulz; Herbert de Groot
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

5.  Glycine protection of PC-12 cells against injury by ATP-depletion.

Authors:  Kan Zhang; Joel M Weinberg; Manjeri A Venkatachalam; Zheng Dong
Journal:  Neurochem Res       Date:  2003-06       Impact factor: 3.996

6.  Glycine transporter GLYT1 is essential for glycine-mediated protection of human intestinal epithelial cells against oxidative damage.

Authors:  Alison Howard; Imran Tahir; Sajid Javed; Sarah M Waring; Dianne Ford; Barry H Hirst
Journal:  J Physiol       Date:  2010-02-01       Impact factor: 5.182

7.  Glycine provokes lipid oxidative damage and reduces the antioxidant defenses in brain cortex of young rats.

Authors:  Guilhian Leipnitz; Alexandre F Solano; Bianca Seminotti; Alexandre U Amaral; Carolina G Fernandes; Ana Paula Beskow; Carlos S Dutra Filho; Moacir Wajner
Journal:  Cell Mol Neurobiol       Date:  2008-10-02       Impact factor: 5.046

8.  Glycine protects cardiomyocytes against lethal reoxygenation injury by inhibiting mitochondrial permeability transition.

Authors:  Marisol Ruiz-Meana; Pilar Pina; David Garcia-Dorado; Antonio Rodríguez-Sinovas; Ignasi Barba; Elisabet Miró-Casas; Maribel Mirabet; Jordi Soler-Soler
Journal:  J Physiol       Date:  2004-06-24       Impact factor: 5.182

9.  Glycine reduces platelet aggregation.

Authors:  Peter Schemmer; Zhi Zhong; Uwe Galli; Michael D Wheeler; Li Xiangli; Blair U Bradford; Lars O Conzelmann; Dow Forman; José Boyer; Ronald G Thurman
Journal:  Amino Acids       Date:  2012-11-08       Impact factor: 3.520

10.  HEGPOL: randomized, placebo controlled, multicenter, double-blind clinical trial to investigate hepatoprotective effects of glycine in the postoperative phase of liver transplantation [ISRCTN69350312].

Authors:  Steffen P Luntz; Kristina Unnebrink; Monika Seibert-Grafe; Hartwig Bunzendahl; Thomas W Kraus; Markus W Büchler; Ernst Klar; Peter Schemmer
Journal:  BMC Surg       Date:  2005-08-17       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.